Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI tailor discharge instructions to boost heart surgery recovery?

NCT ID NCT07780994

Symptom relief Sponsor: Izmir Katip Celebi University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 24, 2026 · Last updated Aug 25, 2026 · Updated 1 time

Summary

This trial asks whether discharge education personalized by artificial intelligence can improve recovery after coronary artery bypass grafting. About 80 adults who have had elective bypass surgery will be randomly assigned to receive either standard discharge education or standard education plus AI-generated individualized instruction tailored to their health literacy, needs, and surgical details. Researchers will measure readiness for discharge, recovery progress, satisfaction, self-care adherence, complications, and unplanned hospital visits over 30 days after leaving the hospital.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial intelligence-supported individualized discharge education
What this could lead to
If effective, this approach could become a standard way to prepare heart surgery patients for discharge, potentially reducing complications and unplanned hospital visits.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. The benefit of AI-tailored education over standard care is unproven, and outcomes depend on patient engagement and follow-up.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older. * Having undergone elective isolated coronary artery bypass grafting. * Ability to communicate in Turkish. * No cognitive or communication impairment that would prevent participation in the study. * Voluntary agreement to participate in the study and provision of written informed consent. Exclusion Criteria: * Refusal to participate in the study or failure to provide written informed consent. * Age under 18 years. * Inability to communicate in Turkish. * Cognitive impairment, delirium, dementia, or a severe psychiatric condition preventing completion of the data collection tools. * Having undergone emergency surgery. * Presence of a severe postoperative complication preventing delivery of the planned discharge education. * Inability to be reached during the follow-up period. * Incomplete completion of the data collection forms. * Withdrawal from the study at any stage.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery bypass grafting are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery bypass grafting Postoperative recovery

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.